Serum Institute of India is an Indian biotechnology and biopharmaceuticals company. It is the world's largest manufacturer of vaccines located in the city of Pune, India and was founded by Cyrus Poonawalla in 1966. Read More
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine -- Covovax for use for children and adults, on April 1, sources informed on Wednesday. ...
Novavax on Tuesday announced the first emergency use authorization of its COVID-19 vaccine for adolescents falling in the age bracket of 12-18 years in India. ...
The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of India's (SII) COVID-19 vaccine Covovax for adults and for children above the age of 12 years. ...
After the Covovax vaccine got WHO's approval for emergency use, Chief Executive Officer of the Serum Institute of India Adar Poonawalla on Friday said that this is yet another milestone in our fight against COVID-19. ...
Serum Institute of India (SII) executive director Suresh Jadhav, who played an instrumental role in the field of vaccine manufacturing in India, passed away on Wednesday. ...
Chief Executive Officer of the Serum Institute of India (SII) Adar Poonawalla on Wednesday said that COVID-19 vaccine hesitancy is the greatest threat in overcoming the pandemic. ...
